[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335661-105":59,"doc-detail-335661-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","kdm5d-histone-demethylase-mediates-p38-inactivation-via-its-enzymatic-activity-to-inhibit-cancer-progression-research-findings-summary","KDM5D histone demethylase mediates p38α inactivation via its enzymatic activity to inhibit cancer progression - Research findings summary","","The study investigates how the histone demethylase KDM5D regulates p38α signaling to restrain cancer progression. It identifies p38α methylation at lysine 165 (K165) as a modification that promotes p38α phosphorylation in tumor cells. KDM5D is shown to interact with p38α and demethylate K165, impairing p38α activation and suppressing tumor progression in vitro and in vivo. KDM5D expression is low in NSCLC, and higher KDM5D correlates with improved cancer survival, with reduced proliferation and migration observed in xenograft models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/kdm5d-histone-demethylase-mediates-p38-inactivation-via-its-enzymatic-activity-to-inhibit-cancer-progression-research-findings-summary/335661/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/kdm5d-histone-demethylase-mediates-p38-inactivation-via-its-enzymatic-activity-to-inhibit-cancer-progression-research-findings-summary/335661.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does KDM5D play in regulating p38α?","Question",{"text":112,"@type":113},"KDM5D interacts with p38α and demethylates it at lysine 165 (K165). This demethylation inhibits p38α phosphorylation and suppresses tumor progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does K165 methylation affect p38α in tumor cells?",{"text":117,"@type":113},"p38α methylation at K165 promotes its phosphorylation in tumor cells. Blocking this methylation reduces p38α activation and represses cancer progression in vitro and in vivo.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the significance of KDM5D expression in NSCLC?",{"text":121,"@type":113},"KDM5D is expressed at low levels in NSCLC, and higher KDM5D expression is positively correlated with cancer survival. In xenograft models, KDM5D markedly inhibits cell proliferation and migration via p38α inactivation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335661,1790252511,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","KDM5D histone demethylase mediates p38α inactivation via its enzymatic activity to inhibit cancer progression  \nJingying Chena, b,1, Ting Wanga,1, Dongzhe Zhanga, Huiling Wanga, Zhiang Huangc, Zhongxin Yangc, Jizhuo Lia, Tianyi Hua, Xin Wanga, and Xia Lia, b,2 Affiliations are included on p. 10.  \nEdited by Melanie Cobb, The University of Texas Southwestern Medical Center, Dallas, TX; received March 7, 2024; accepted October 16, 2024  \nThe p38 MAP kinase (MAPK) signaling pathway plays pivotal roles in various cellular processes. Phosphorylation serves as a canonical way to regulate p38α activation through a phosphorylation cascade. Thus, understanding the mechanism governing p38α phosphorylation is important. The present study demonstrated that p38α undergoes methylation at K165, which promote its phosphorylation in tumor cells. Inhibition of p38α methylation impairs p38α phosphorylation, repressing tumor progression in vitro and in vivo. Mechanistically, KDM5D is a demethylase that interacts with p38α, mediating demethylation at K165 and inhibiting p38α phosphorylation. Moreover, KDM5D is expressed at low levels in non–small cell lung cancer (NSCLC), and high KDM5D expression is positively correlated with cancer survival. KDM5D markedly inhibits cell proliferation and migration via inactivating p38α, thereby slowing cancer progression in xenograft models. In summary, these findings highlight KDM5D as a demethylase ofp38α at K165, elucidating a unique role for lysine demethylation in integrating cytoplasmic kinase-signaling cascades. The present results revealed the critical role of KDM5D in suppressing tumor progression, suggesting that KDM5D can serve as a potential drug target for combating hyperactive p38α-driven lung cancer.  \ndemethylation | p38α | KDM5D | post-translational modifications | cancer progression  \nLung cancer ranks as the most frequently diagnosed cancer and remains the leading cause of cancer-related mortality worldwide (1, 2) . NSCLC constitutes approximately 85% of all lung cancer cases, and early-stage NSCLC is generally treated via surgical resection, resulting in survival rates ranging from 35% to 85%, contingent upon the tumor stage (1, 3). In recent years, specific factors, such as kinase signaling pathway-related components, have been the focus of targeted therapies for lung cancer. However, there is a need to identify novel drug targets that offer alternative avenues for NSCLC-targeted treatments (4) . Therefore, it is imperative to understand the molecular mechanism of lung cancer and discover new potential drug targets.  \nPosttranslational modifications (PTMs) play crucial roles in regulating cellular signal transduction during tumor progression (5, 6) . Among these, lysine methylation is a well-recognized PTM (7) . Methylation oflysine residues in nonhistone proteins involves various molecular processes, including protein–protein interactions, stabilization, subcellular localization, and modifications (8–11) . The activation of p38α is crucial for cell proliferation, migration, and adhesion in several cancers, including colon cancer, breast cancer, and lung cancer (12–15) . The active state of p38α is tightly controlled by the MAPK signaling pathway through phosphorylation. Several PTMs of p38α, which regulate its activation, have been identified in cancer. For example, the phosphorylation ofp38α at Thr180/Tyr182 is essential for its activation (16). Additionally, the acetylation ofp38α at K53 enhances its activity by promoting ATP binding (17) . Recent research has indicated that lysine residues in p38α undergo methylation by the enhancer of zeste homolog 2  \n(EZH2) methyltransferase (18) . However, the demethylases involved in regulating the activation and kinase activity of p38α remain largely unidentified.  \nLysine methylation is a reversible modification that is dynamically regulated by protein lysine methyltransferases (PKMTs) and protein lysine demethylases (PKDMs) (19) . Accumulating ev","cbCaik9BPYrwB0fK","https://ap.wps.com/l/cbCaik9BPYrwB0fK","pdf",18744512,"English","# Background\n## p38α signaling and activation by phosphorylation\n## Post-translational modifications and lysine methylation\n# Study focus and significance\n## Identifying KDM5D as a p38α demethylase\n## KDM5D-mediated inhibition of p38α phosphorylation\n# Findings and implications\n## Effects on proliferation, migration, and tumor progression\n## Clinical relevance and biomarker potential\n## Therapeutic targeting of KDM5D","[{\"question\":\"What role does KDM5D play in regulating p38α?\",\"answer\":\"KDM5D interacts with p38α and demethylates it at lysine 165 (K165). This demethylation inhibits p38α phosphorylation and suppresses tumor progression.\"},{\"question\":\"How does K165 methylation affect p38α in tumor cells?\",\"answer\":\"p38α methylation at K165 promotes its phosphorylation in tumor cells. Blocking this methylation reduces p38α activation and represses cancer progression in vitro and in vivo.\"},{\"question\":\"What is the significance of KDM5D expression in NSCLC?\",\"answer\":\"KDM5D is expressed at low levels in NSCLC, and higher KDM5D expression is positively correlated with cancer survival. In xenograft models, KDM5D markedly inhibits cell proliferation and migration via p38α inactivation.\"}]","KDM5D histone demethylase mediates p38α inactivation via its enzymatic activity to inhibit cancer progression - Research findings summary | PDF",1790011857,25]